Research Topics
| Larry A GreenbaumSummaryAffiliation: Emory University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Current advances in chronic kidney disease in children: growth, cardiovascular, and neurocognitive risk factorsLarry A Greenbaum
Division of Pediatric Nephrology, Department of Pediatrics, Emory University, 2015 Uppergate Drive NE, Atlanta, GA 30322, USA
Semin Nephrol 29:425-34. 2009..Other early cardiovascular complications in children with CKD include left ventricular hypertrophy, cardiac dysfunction, and vascular calcifications...- The association between abnormal birth history and growth in children with CKDLarry A Greenbaum
Division of Pediatric Nephrology, Emory University, 2015 Uppergate Drive, NE, Atlanta, GA 30322, USA
Clin J Am Soc Nephrol 6:14-21. 2011.... - Association between clinical risk factors and progression of chronic kidney disease in childrenAmy O Staples
Department of Pediatrics, University of New Mexico, Albuquerque, NM 87131, USA
Clin J Am Soc Nephrol 5:2172-9. 2010..There is a need to identify treatments to slow the progression of CKD, yet there are limited data regarding clinical risk factors that may be suitable targets to slow progression... 
Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysisLarry A Greenbaum
Emory University and Children s Healthcare of Atlanta, GA 30322, USA
Am J Kidney Dis 49:814-23. 2007..Paricalcitol, a selective vitamin D receptor activator, causes less sustained hypercalcemia and increase in Ca x P product than calcitriol and has been used effectively in adult hemodialysis patients...
Prevalence of sleep disturbances in children and adolescents with chronic kidney diseaseIra D Davis
Department of Pediatrics, Rainbow Babies and Children s Hospital Case Western Reserve University, Cleveland, OH, USA
Pediatr Nephrol 27:451-9. 2012..We conclude that sleep disturbances are common throughout the spectrum of chronic kidney disease in children and adolescents and are associated with diminished health-related quality of life scores...- Obstacles to the prescribing of growth hormone in children with chronic kidney diseaseLarry A Greenbaum
Department of Pediatrics, Division of Pediatric Nephrology, Emory University and Children s Healthcare of Atlanta, 2015 Uppergate Drive, NE, Atlanta, GA, 30322, USA
Pediatr Nephrol 23:1531-5. 2008..The fact that more than 50% of short children with CKD did not receive rhGH is secondary to multiple factors, many of which may be amenable to intervention efforts... - Anemia and risk of hospitalization in pediatric chronic kidney diseaseAmy O Staples
Division of Pediatric Nephrology, University of New Mexico, Albuquerque, NM 87131, USA
Clin J Am Soc Nephrol 4:48-56. 2009..Additionally, the associated morbidity of anemia in the pediatric CKD population has not been elucidated... - Vesicoureteral refluxLarry A Greenbaum
Division of Pediatric Nephrology, Emory University School of Medicine, Children s Healthcare of Atlanta, 2015 Uppergate Drive NE, Atlanta, GA 30322, USA
Pediatr Clin North Am 53:413-27, vi. 2006..New insights into pathogenesis and new surgical techniques are changing the approach to the management of this disorder... - Tacrolimus withdrawal and conversion to sirolimus at three months post-pediatric renal transplantationLeonard C Hymes
Department of Pediatrics, Emory University School of Medicine and Children s Healthcare of Atlanta, Atlanta, GA, USA
Pediatr Transplant 12:773-7. 2008..While these early results are promising, the ultimate benefit of this protocol to enhance the long-term renal function and graft survival requires ongoing follow-up... - Prevalence of clinical rejection after surveillance biopsies in pediatric renal transplants: does early subclinical rejection predispose to subsequent rejection episodes?Leonard C Hymes
Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA
Pediatr Transplant 13:823-6. 2009..Renal function and graft survival at 30 months also were no different between patients with SCR and those with normal SB. Early-SCR, when treated with rejection protocols, is not a prognostic indicator for subsequent CR episodes... - Renal dysplasia and MRI: a clinician's perspectiveLarry A Greenbaum
Division of Pediatric Nephrology, Children s Healthcare of Atlanta, Emory University, 2015 Uppergate Drive NE, Atlanta, GA 30322, USA
Pediatr Radiol 38:S70-5. 2008..The emphasis is on the important clinical issues, and the potential of MRI as a methodology for providing clinically useful information not otherwise available from other imaging modalities... - Effect of intensified diet education on serum phosphorus and knowledge of pediatric peritoneal dialysis patientsEmily L Abercrombie
Children s Healthcare of Atlanta, Atlanta, GA, USA
J Ren Nutr 20:193-8. 2010..To investigate the effect of intensive diet education on the knowledge and serum phosphorus levels of pediatric peritoneal dialysis (PD) patients and their parents... - Risk factors for early peritoneal dialysis catheter failure in childrenRandolph K Cribbs
Division of Pediatric Surgery, Department of Surgery, Emory University, Atlanta, GA 30322, USA
J Pediatr Surg 45:585-9. 2010..Operative technique, catheter selection, and patient variables (eg, age or prior surgical history) may influence catheter lifespan... - Delay in diagnosis in poststreptococcal glomerulonephritisPriya J Pais
Department of Pediatrics, Medical College of Wisconsin and Children s Research Institute of Children s Hospital of Wisconsin, Milwaukee, WI, USA
J Pediatr 153:560-4. 2008..To determine the frequency and risk factors for diagnostic delays in children with poststreptococcal glomerulonephritis (PSGN)... - Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysisLarry A Greenbaum
Department of Pediatrics, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226, USA
Pediatr Nephrol 20:622-30. 2005..This study demonstrates that i.v. calcitriol, at initial doses of 0.5-1.5 microg, effectively reduces PTH levels in pediatric HD patients and that patients should be closely monitored for hyperphosphatemia and elevated Ca x P product... - Rationale for growth hormone therapy in children with chronic kidney diseaseLarry A Greenbaum
Medical College of Wisconsin, Department of Pediatrics, 8701 Watertown Plank Rd, Milwaukee, WI 53226, USA
Adv Chronic Kidney Dis 11:377-86. 2004..Administration of recombinant human growth hormone can overcome this problem, allowing catch-up growth and achievement of normal or improved adult height... - Nephrotic syndrome after conversion to alternate day steroids in two children with a history of recurrent FSGSCoral D Hanevold
Department of Pediatrics, Medical College of Georgia, Augusta, GA 30912 3795, USA
Pediatr Transplant 7:395-9. 2003..Nephrotic syndrome reappeared years later when the patients were converted from daily to alternate day prednisone. In children with a history of FSGS, caution is necessary when altering the dosing schedule of prednisone... - Follow-up urine cultures and fever in children with urinary tract infectionMelissa L Currie
Department of Pediatrics, Medical College of Wisconsin, Milwaukee 53226, USA
Arch Pediatr Adolesc Med 157:1237-40. 2003..Fever beyond 48 hours is common and should not be used as a criterion for obtaining a repeat urine culture. These conclusions are valid for children with vesicoureteral reflux. Such an approach would result in significant cost savings...